Oncology
HR+/HER2- Early Breast Cancer
Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at SABCS 2025
Overview
<div class="bodytext_module_container">
<div class="bodytext_module_body">
<p>Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Early Breast Cancer presented at the San Antonio Breast Cancer Symposium 2025.</p>
<p><br></p>
<p><strong>VIEW THE TOPICS: </strong></p>
<ul>
<li>Adjuvant Therapy for Early-Stage HR+/HER2- Breast Cancer</li>
<li>Precision Medicine in Early-Stage HR+/HER2- Breast Cancer</li>
<li>SABCS 2025 Highlights and Early-Stage HR+/HER2- Breast Cancer</li>
<li>Treatment Options for Stage III HR+/HER2- Breast Cancer</li>
</ul>
<div class="overview">
<p><br></p>
<p><em>This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the San Antonio Breast Cancer Symposium.</em></p>
</div>
<p><br></p>
<p style="text-align: center;">SABCS 2025</p>
<p style="text-align: center;"><span class="dash">December 9–</span> December 13, 2025</p>
<p style="text-align: center;">Henry B. Gonzalez Convention Center, San Antonio, Tx & Online</p>
<p style="text-align: center;"><a href="https://sabcs.org/Registration/">Link to Registration</a></p>
</div>
</div>
